Status:
UNKNOWN
Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19
Lead Sponsor:
Center for Integrated Care
Collaborating Sponsors:
University of Utah
University of California, San Francisco
Conditions:
Coronavirus Infection
Eligibility:
All Genders
18-114 years
Brief Summary
The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.
Detailed Description
The purpose of this study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19 infec...
Eligibility Criteria
Inclusion
- Eighteen year of age.
- Experienced one or more of the following symptoms in the last 28 days: cough, fever, shortness of breath, diarrhea, nausea, or abdominal pain OR am at high risk of exposure.
- Have a Primary Care Provider.
Exclusion
- Breastfeeding, pregnant, or expect that I might be pregnant.
- Ineligible to receive a telehealth consult for any reason.
- Unable to communicate in English verbally, and in writing.
- Have an open legal case about my health.
- Taking anticoagulants, immunosuppressants, antiseizure medications, antipsychotic medications or am in active cancer treatment
- Taking medications with some risk of interaction with the herbal medicine. This will be determined at the time of the herbal consult by the clinic team.
- Discretion of the practitioner or screener.
Key Trial Info
Start Date :
May 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 11 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04380870
Start Date
May 11 2020
End Date
May 11 2025
Last Update
September 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seattle Intstitute of East Asian Medicine
Seattle, Washington, United States, 98108